Stanford University researchers study concludes that clinical trials can offer patients with Huntington’s disease (HD) hope when there are no treatments available despite unknowns whether the therapy will work or is safe. The study results show that although the HD...
Kaiser Permanente, one of the nation’s largest health systems, conducted a real-world study to find that neurological side effects from phenytoin, an anti-seizure medication, are more common in patients with certain genetic variants. Interestingly, the same genetic...
Thermo Fisher Scientific’s new gene editing tool will help researchers find therapies for cancer and other diseases. Called the Invitrogen LentiArray CRISPR Libraries, it is a ready-to-use array of knockout libraries for the human genome. The library suite offers...
The University of British Columbia (UBC), BC Children’s Hospital, and an international team of investigators published in the New England Journal of Medicine a rarely-seen type of DNA mutation as the potential cause of an inherited metabolic disorder. Often the result...
Icahn Medical School of Medicine, Mount Sinai and Rockefeller University researchers have discovered a new use for a long-standing computational concept known as “blacklisting” as reported in EurekAlert! The blacklisting process is typically used as a form of access...
Read ScienceDaily about pioneering research into the mechanisms controlling gene activity in the brain could hold the key to understanding Alzheimer’s disease and might help identify effective treatments in the future. Lead/Research Jonathan...
